Story Navigation
-
From Our LabsBiomedical ResearchNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesScientific ResearchBiomedical Science
Stopping free radicals at their source
Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.
From Our Labs -
Access to HealthcareAccess to HealthcareCancerChronic IllnessFuture of HealthcareNovartis AccessNovartis Social Business
Confronting the global spread of chronic disease
Chronic diseases like cancer and diabetes were once the preserve of wealthy countries but are now increasingly common in lower-income countries too as populations age and lifestyles change.
Access to Healthcare -
Access to HealthcareAccess to HealthcareDisease EradicationInfectious DiseasesMalariaNovartis Social BusinessTropical Diseases
Malaria fighter rides bicycle into battle with disease
Healthcare worker Dismus Mwalukwanda is on the front line of the battle against malaria. Saving lives is his priority.
Access to Healthcare -
Patient PerspectivesNovartis Institutes for BioMedical ResearchClinical ResearchCareersClinical TrialsClinical Science
Putting patients first
Chinweike Ukomadu thinks that notions about clinicians turning their backs on patients when transitioning to industry are outdated.
Patient Perspectives -
DiscoveryNovartis Institutes for BioMedical ResearchMusculoskeletal DiseasesCareers
Turning research advances into innovative medicines
A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines
Discovery -
From Our LabsBiomedical ResearchNovartis Institutes for BioMedical ResearchPostdoc ProgramScientific Research
Five things to look for in a scientific mentor
From Our Labs -
From Our LabsBiomedical ResearchNovartis Institutes for BioMedical ResearchScientific ResearchBiomedical Science
How I built a mini-gut with next to no biology training
From Our Labs -
DiscoveryNovartis Institutes for BioMedical ResearchRare DiseasesClinical TrialsGenetic Disease
Rewriting the playbook for clinical testing in a rare disease
A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.
Discovery -
Patient PerspectivesChronic IllnessHeart Failure
Surviving with heart failure
Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers.
Patient Perspectives -
Access to HealthcareAccess to Healthcare
Health collaboration in Russia helped reduce blood pressure, deaths
Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to address high death rates from stroke and heart disease.
Access to Healthcare -
From Our LabsDrug DiscoveryNovartis Institutes for BioMedical ResearchRare DiseasesNew Scientific DiscoveriesGenetic Disease
Fixing what’s lost in translation
From Our Labs -
DiscoveryCancerCell and Gene TherapyInnovationMedical Innovations
Could umbilical cords yield more stem cells for life-saving transplants?
Umbilical cords are a potentially life-saving source of blood stem cells for people with leukemia and other diseases. But there aren’t enough cells to meet demand. Now an experimental treatment offers hope for a solution.
Discovery
Pagination
- ‹ Previous page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- …
- 32
- › Next page